project id: TCGA-LUAD; case submitter id: TCGA-64-5774; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22059; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 22059; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2676.0; icd 10 code: C34.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Main bronchus; synchronous malignancy: No; tissue or organ of origin: Main bronchus; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 2.4657534246575343; pack years smoked: 45.0; years smoked: 45.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 1.4; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-64-5774-01A-01; percent necrosis: 3.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 87.0; percent tumor nuclei: 80.0;